Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$6.82 - $13.82 $12,821 - $25,981
-1,880 Reduced 3.22%
56,570 $386,000
Q1 2022

May 05, 2022

SELL
$11.65 - $15.28 $18,407 - $24,142
-1,580 Reduced 2.63%
58,450 $824,000
Q4 2021

Feb 04, 2022

BUY
$12.37 - $16.77 $18,060 - $24,484
1,460 Added 2.49%
60,030 $870,000
Q3 2021

Nov 08, 2021

BUY
$13.7 - $17.25 $186,731 - $235,117
13,630 Added 30.33%
58,570 $829,000
Q2 2021

Aug 09, 2021

BUY
$13.75 - $18.8 $617,925 - $844,872
44,940 New
44,940 $791,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $647M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Affinity Investment Advisors, LLC Portfolio

Follow Affinity Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Investment Advisors, LLC with notifications on news.